Janssen Scientific Affairs

• NCT06329830

  Collaborator, Phase 1/2, Withdrawn, 0 people, 26 Mar 2024

• NCT06142396

  Collaborator, Early phase 1, Recruiting, 30 people, 21 Nov 2023

• NCT06014385

  Collaborator, Phase 1, Withdrawn, 0 people, 28 Aug 2023

• NCT05463783

  Collaborator, Phase 4, Status unknown, 30 people, 19 Jul 2022

• NCT05231629

  Collaborator, Phase 2, Active, not recruiting, 300 people, 9 Feb 2022

• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  Collaborator, Phase 3, Active, not recruiting, 1,683 people, 17 Sept 2021

• NCT04933539

  Collaborator, Phase 2, Active, not recruiting, 14 people, 21 Jun 2021

• NCT04439006

  Collaborator, Phase 1, Completed, 10 people, 19 Jun 2020

• NCT04388904

  Collaborator, Phase 4, Completed, 75 people, 14 May 2020

• NCT04352205

  Collaborator, Phase 2, Terminated, 17 people, 20 Apr 2020

• NCT04302324

  Collaborator, Phase 2, Active, not recruiting, 11 people, 10 Mar 2020

• NCT04270175

  Collaborator, Phase 2, Active, not recruiting, 15 people, 17 Feb 2020

• NCT04267887

  Collaborator, Phase 2, Active, not recruiting, 7 people, 13 Feb 2020

• NCT04223661

  Collaborator, Phase 2, Withdrawn, 0 people, 10 Jan 2020

• NCT04151667

  Collaborator, Phase 2, Completed, 33 people, 5 Nov 2019

• NCT04140162

  Collaborator, Phase 2, Active, not recruiting, 57 people, 25 Oct 2019

• NCT04139304

  Collaborator, Early phase 1, Recruiting, 15 people, 25 Oct 2019

• NCT04059679

  Collaborator, Phase 4, Status unknown, 30 people, 16 Aug 2019

• NCT04009109

  Collaborator, Phase 2, Active, not recruiting, 79 people, 5 Jul 2019

• NCT03939182

  Collaborator, Phase 1, Completed, 15 people, 6 May 2019

Sources: clinicaltrials.gov